1 unchanged sentence
Insider Trading Arrangements
−Removed: During the three months ended March 31, 2026 , no director or officer of the Company adopted or terminated a Rule 10b5 - 1 trading arrangement or non-Rule 10b5 - 1 trading arrangement, as each term is defined in Item 408 (a) of Regulation S-K.
+Added: During the three months ended June 30, 2026 , no director or officer of the Company adopted or terminated a Rule 10b5 - 1 trading arrangement or non-Rule 10b5 - 1 trading arrangement, as each term is defined in Item 408 (a) of Regulation S-K.
EXHIBIT INDEX
62 unchanged sentences
November 13, 2025
−Removed: Second Amendment to the Employment Agreement of Robert J.
−Removed: Bitterman, dated February 17, 2026, by and between Robert J.
−Removed: Bitterman and Phio Pharmaceuticals Corp.#
−Removed: Current Report on Form 8-K (File No.
−Removed: February 18, 2026
At the Market Offering Agreement, by and between the Company and H.C.
14 unchanged sentences
Furnished herewith and not deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that Section or incorporated by reference into any filing under the Securities Act or the Exchange Act.
−Removed: Indicates a management contract or compensatory plan or arrangement.
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on May 7, 2026.
+Added: Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on August 6, 2026.
Phio Pharmaceuticals Corp.
5 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.